Crescent Biopharma Insider Sales Surge: Executives Dump Shares in Coordinated Tax‑Strategy Move
Explore why Crescent Biopharma’s insider sales on June 22, 2026—especially the CEO’s 42k‑share exit—signal tax strategy, not a company slump.
3 minutes to read